SEC Subpoenas SeraCare Following Claims That Past Financials Are Unreliable | GenomeWeb

NEW YORK, Apr. 12 (GenomeWeb News) - SeraCare Life Sciences has received a subpoena from the Securities and Exchange Commission for documents related to its business.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.